Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

Core Insights - Nautilus Biotechnology, Inc. is participating in the TD Cowen 45th Annual Healthcare Conference, highlighting its engagement in the healthcare sector [1] - The management of Nautilus is scheduled for a fireside chat on March 3, 2025, at 1:50 p.m. Eastern Time, which will be accessible via a live and archived webcast [2] - Nautilus is a development stage life sciences company focused on creating a platform technology for quantifying the proteome, aiming to democratize access to proteomics and advance human health and medicine [3] Company Overview - Nautilus Biotechnology is headquartered in Seattle, with its research and development center located in the San Francisco Bay Area [3] - The company's mission is to transform the field of proteomics by enabling significant advancements in human health and medicine [3]